Abstract:Background: Anti-viral CD8 T-cell activity is enhanced and prolonged by CD4 T-cell-mediated help, but negatively regulated by inhibitory B7-H1 interactions. During viral encephalomyelitis, the absence of CD4 T cells decreases CD8 T cell activity and impedes viral control in the central nervous system (CNS). By contrast, the absence of B7-H1 enhances CD8 T-cell function and accelerates viral control, but increases morbidity. However, the relative contribution of CD4 T cells to CD8 function in the CNS, in the absence of B7-H1, remains unclear. Methods: Wild-type (WT) and B7-H1-/- mice were infected with a gliatropic coronavirus and CD4 T cells depleted to specifically block T helper function in the CNS. Flow cytometry and gene expression analysis of purified T-cell populations from lymph nodes and the CNS was used to directly monitor ex vivo T-cell effector function. The biological affects of altered T-cell responses were evaluated by analysis of viral control and spinal-cord pathology. Results: Increased anti-viral activity by CD8 T cells in the CNS of B7-H1-/- mice was lost upon depletion of CD4 T cells; however, despite concomitant loss of viral control, the clinical disease was less severe. CD4 depletion in B7-H1-/- mice also decreased inducible nitric oxide synthase expression by microglia and macrophages, consistent with decreased microglia/macrophage activation and reduced interferon (IFN)-γ. Enhanced production of IFN-γ, interleukin (IL)-10 and IL-21 mRNA was seen in CD4 T cells from infected B7-H1-/- compared with WT mice, suggesting that over-activated CD4 T cells primarily contribute to the increased pathology. Conclusions: The local requirement of CD4 T-cell help for CD8 T-cell function is not overcome if B7-H1 inhibitory signals are lost. Moreover, the increased effector activity by CD8 T cells in the CNS of B7-H1-/- mice is attributable not only to the absence of B7-H1 upregulation on major histocompatibility complex class I-presenting resident target cells, but also to enhanced local CD4 T-cell function. B7-H1-mediated restraint of CD4 T-cell activity is thus crucial to dampen both CD8 T-cell function and microglia/macrophage activation, thereby providing protection from T-cell-mediated bystander damage.

Permission of Pathogen Expansion Inside a Specialized DC by a Co-Inhibitory Pathway Dictates T Cell Response (P4249)

A BTLA-mediated bait and switch strategy permits Listeria expansion in CD8α(+) DCs to promote long-term T cell responses.

HVEM-BTLA Interactions Regulate Early CD8+ T Cell Response Against Listeria Monocytogenes (88.33)

B and T Lymphocyte Attenuator Tempers Early Infection Immunity

Bcl6 Sets a Threshold for Antiviral Signaling by Restraining IRF7 Transcriptional Program

The Inhibitory HVEM-BTLA Pathway Counter Regulates Lymphotoxin Β Receptor Signaling to Achieve Homeostasis of Dendritic Cells

B and T lymphocyte attenuator regulates CD8 + T cell–intrinsic homeostasis and memory cell generation

Distinct Expression and Inhibitory Function of B and T Lymphocyte Attenuator on Human T Cells

Regulatory T Cell Expression of Herpesvirus Entry Mediator Suppresses the Function of B and T Lymphocyte Attenuator-Positive Effector T Cells.

Engagement of B7 on Effector T Cells by Regulatory T Cells Prevents Autoimmune Disease.

T Cell-Derived Lymphotoxin is Essential for the Anti-Herpes Simplex Virus 1 Humoral Immune Response

Expression of B and T Lymphocyte Attenuator (BTLA) in Macrophages Contributes to the Fulminant Hepatitis Caused by Murine Hepatitis Virus Strain-3

Correction: Soluble B and T Lymphocyte Attenuator Possesses Antitumor Effects and Facilitates Heat Shock Protein 70 Vaccine-Triggered Antitumor Immunity Against a Murine TC-1 Cervical Cancer Model in Vivo

Cutting Edge: B and T Lymphocyte Attenuator Signaling on NKT Cells Inhibits Cytokine Release and Tissue Injury in Early Immune Responses.

Tumor Cell-Intrinsic BTLA Receptor Inhibits the Proliferation of Tumor Cells via ERK1/2

Cd11c(High)Cd8(+) Regulatory T Cell Feedback Inhibits Cd4 T Cell Immune Response Via Fas Ligand-Fas Pathway

Critical Role for Perforin-, Fas/FasL-, and TNFR1-Mediated Cytotoxic Pathways in Down-Regulation of Antigen-Specific T Cells During Persistent Viral Infection

Enhanced CD8 T-cell anti-viral function and clinical disease in B7-H1-deficient mice requires CD4 T cells during encephalomyelitis

Hepatic Expansion of Virus-Specific CD8+BTLA+ T Cells with Regulatory Properties in Chronic Hepatitis B Virus Infection.

T cell-derived lymphotoxin limits Th1 response during HSV-1 infection.

CD8+ T Cells Mediate Lethal Lung Pathology in the Absence of PD-L1 and Type I Interferon Signalling following LCMV Infection